Scott, Bart L and Park, J Y and Deeg, H Joachim and Marr, Kieren A and Boeckh, Michael and Chauncey, Thomas R and Appelbaum, Frederick R and Storb, Rainer and Storer, Barry E (2008) Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 14 (7). pp. 799-806. ISSN 1523-6536
Preview |
Text (Complete manuscript)
Scott_neutropenia-ms_accepted_4-23-08.pdf Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (130kB) | Preview |
Abstract
A retrospective cohort analysis was performed to determine the impact of neutropenia on the outcome of hematopoietic cell transplantation (HSCT) in patients with myelodysplasia (MDS). Among 291 consecutive patients, 178 (61%) had absolute neutrophil counts (ANCs) <1500/microL and 113 (39%) had ANCs > or =1500/microL within 2 weeks before HSCT. Neutropenic patients more often had poor-risk karyotypes (34% versus 12%, P < .0001) and high-risk International Prognostic Scoring System scores (37% versus 18%, P = .0006). After HSCT, the rate of infections caused by Gram-positive bacteria and invasive fungal infections was significantly increased among neutropenic patients (rate ratio [RR] 1.77, P = .02 and RR = 2.56, P = .03, respectively), whereas infections caused by Gram-negative bacteria were not affected (RR 1.33, P = .53). The hazards of nonrelapse mortality (NRM) (hazard ratio [HR] = 1.62 [1.1-2.4], P = .01), overall mortality (HR = 1.55 [1.1-2.1], P = 0.007), and infection-related mortality (HR = 2.22 [1.2-4.2], P = .01) were increased in neutropenic patients, whereas relapse, engraftment, and graft-versus-host-disease were not affected. After adjusting for cytogenetic risk and marrow myeloblast percentages, neutropenic patients remained at significant hazard for infection-related mortality (HR = 1.94 [1.0-3.8], P = .05), but not for overall mortality or NRM. We propose that intensified strategies to prevent infections should be implemented in MDS patients with preexisting neutropenia who undergo HSCT.
| Item Type: | Article or Abstract |
|---|---|
| DOI: | 10.1016/j.bbmt.2008.04.011 |
| PubMed ID: | 18541200 |
| NIHMSID: | NIHMS55739 |
| PMCID: | PMC2587376 |
| Other ID: | RM1256,rs12 |
| Grant Numbers: | HL084054, HL36444, CA18029, CA15704, HL82941 |
| Keywords or MeSH Headings: | Adolescent Adult Aged Bacterial Infections/etiology* Child Child, Preschool Cohort Studies Cross Infection/etiology Female Hematopoietic Stem Cell Transplantation/adverse effects* Humans Infant Male Middle Aged Mycoses/etiology* Myelodysplastic Syndromes/complications* Myelodysplastic Syndromes/therapy* Neutropenia/complications* Odds Ratio Retrospective Studies Survival Analysis |
| Subjects: | Diseases > Bacterial and fungal diseases Cell Types > Blood and Immune Cells Therapeutics > Transplantation > Stem Cell transplantation Diseases > Hematologic and lymphatic diseases > Myelodysplastic syndrome |
| Depositing User: | Library Staff |
| Date Deposited: | 14 Aug 2008 22:27 |
| Last Modified: | 02 Mar 2012 21:37 |
| URI: | http://authors.fhcrc.org/id/eprint/11 |
Repository Administrators Only
 |
View Item |
